Effects of Enriched Fruit Juice on Blood Glucose Levels After a Meal in Healthy Subjects (PolyGlucHeal)
Primary Purpose
Hyperglycemia, Postprandial, Healthy
Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Enriched pomegranate juice
Placebo beverage
Sponsored by
About this trial
This is an interventional prevention trial for Hyperglycemia, Postprandial focused on measuring Polyphenols, Hyperglycemia, Postprandial, Starch, Alpha-amylase
Eligibility Criteria
Inclusion Criteria:
- Fasting glucose ≤ 5.6 mM;
- Body mass index (BMI) ≤ 30;
- Max glucose after the consumption of app. 109g of white bread less than about 8-9 mM (which is typical for the subjects we have measured previously);
Exclusion Criteria:
- Smoking;
- Participating in another trial that requires blood collection;
- Diagnosed with any chronic illness (including diabetes, hypertension etc.);
- On long term prescribed medication (except contraceptives);
- Pregnant or lactating;
- On a special diet or dietary regimen (for weight management or if regularly consuming fruit extract supplements);
- Allergy to fruits vegetables or pollen.
Sites / Locations
- School of Food Science and Nutrition, University of LeedsRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Enriched pomegranate juice
Placebo beverage
Arm Description
Participants will consume 200 ml of pure pomegranate juice enriched with grape seed and apple peel extracts concomitantly with 109 g of white bread
Participants will consume 200 ml of placebo drink concomitantly with 109 g of white bread
Outcomes
Primary Outcome Measures
Changes in maximal incremental plasma glucose level (iCmax) between baseline and endpoint within the intervention group vs. placebo control.
The incremental glucose levels will be determined for each time point (at 15, 30, 45, 60, 90, 120, 150 and 180 min) as the change in plasma glucose levels after the consumption of enriched pomegranate juice or placebo drink concomitantly with white bread, compared to the glucose levels before the consumption of test meals (baseline value, t=0min).
Secondary Outcome Measures
Changes in area under the curve of incremental plasma glucose levels (iAUC) in the intervention group vs. placebo control.
The glucose iAUC will be determined from all incremental plasma glucose levels at the defined time points (0, 15, 30, 45, 60, 90, 120, 150 and 180 min) after the consumption of test and control meals based on trapezoid rule.
Changes in plasma insulin levels between baseline and endpoint within the intervention group vs. placebo control.
Insulin levels measured at the baseline and at each time point (at 15, 30, 45, 60, 90,120, 150 and 180 min) after the consumption of test and control meals.
Changes in plasma gastric inhibitory peptide (GIP) levels between baseline and endpoint within the intervention group vs. placebo control.
GIP levels measured in plasma at the baseline and at each time point (at 15, 30, 45, 60, 90,120, 150 and 180 min) after the consumption of test and control meals.
Changes in glucagon-like peptide-1 (GIP-1) levels between baseline and endpoint within the intervention group vs. placebo control.
GLP-1 levels measured in plasma at the baseline and at each time point (at 15, 30, 45, 60, 90,120, 150 and 180 min) after the consumption of test and control meals.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03255876
Brief Title
Effects of Enriched Fruit Juice on Blood Glucose Levels After a Meal in Healthy Subjects
Acronym
PolyGlucHeal
Official Title
Effects of Enriched Fruit Juice on Blood Glucose Levels After a Meal in Healthy Subjects
Study Type
Interventional
2. Study Status
Record Verification Date
June 2018
Overall Recruitment Status
Unknown status
Study Start Date
April 10, 2017 (Actual)
Primary Completion Date
August 20, 2018 (Anticipated)
Study Completion Date
September 1, 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Leeds
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Results from a large number of studies in humans have shown that diets rich in foods that give lower glucose response bring lower risk of type 2 diabetes. Polyphenols, naturally found in fruits, vegetables and grains, have shown the potential to attenuate post-prandial blood glucose spikes following a carbohydrate-rich meal, through partial inhibition of the main enzymes of carbohydrate digestion and reduction in glucose and fructose transport from the gut after digestion and by enhancing the insulin action after glucose reaches the bloodstream.
This study is designed to determine whether polyphenols, as normally and naturally present in food extracts and beverages, added to a carbohydrate-rich meal, can lower blood glucose levels after its consumption, and hence lower its glycaemic index, and if this effect is mediated through effects on insulin and other hormones. The study is designed as an acute, double-blind, randomised, placebo-controlled crossover trial in 24 healthy subjects with normal glycaemic response to white bread. Participants will be asked to consume either white bread with pomegranate juice enriched with extracts from grape seeds and apple peels or white bread with placebo drink. The effects on plasma glucose levels, levels of hormones and other biomarkers involved in postprandial response will be determined over 3 hours after the consumption.
Detailed Description
Consumption of carbohydrate-rich foods or sugary drinks affects blood glucose levels. Results from a large number of studies in humans have shown that diets rich in foods that give lower glucose response beneficially affect elevated fasting blood glucose and insulin levels, increase the sensitivity to insulin, contribute to the reduction of body weight and lipids levels and ultimately bring lower risk of type 2 diabetes.
Blood glucose responses depend on the amount and type of carbohydrate(s) present in the meal. Difference in post-prandial blood glucose response to different types of carbohydrates is mainly due to the different rate of their digestion. However, response to the same carbohydrate-rich food can be different between different individuals. Blood glucose levels after carbohydrate-rich meal are shown to be significantly higher in subjects on high-fat diet, in overweight or obese people, or in subjects with different levels of digestive enzymes.
Results from in vitro studies indicate the potential of polyphenols, naturally found in fruits, vegetables and grains, to attenuate post-prandial blood glucose spikes following a carbohydrate-rich meal. It was previously shown that different polyphenols can slow down carbohydrate digestion through partial inhibition of the main enzymes involved, can decrease glucose and fructose transport from the gut after digestion and can improve the action of insulin after glucose reaches the bloodstream.
In the previous study it was shown that pomegranate juice attenuates the increase in blood glucose levels after a starchy meal. This effect is, at least partly, the result of hindered starch digestion by polyphenols present in pomegranate juice.
The present study will determine whether polyphenols, as normally and naturally present in food extracts and beverages, added to a carbohydrate-rich meal, can lower blood glucose levels after its consumption, and hence lower its glycaemic index, and if this effect is mediated through effects on insulin and other hormones or determined by the individual levels of digestive enzymes.
Healthy volunteers will be asked to consume two different meals: (1) white bread with pomegranate juice enriched with extracts from grape seeds and apple peels or (2) white bread with placebo drink with the same type and amount of carbohydrates and similar flavor as enriched pomegranate juice, but without polyphenols.
The levels of glucose, insulin, gastric inhibitory polypeptide (GIP) and glucagon like peptide-1 (GLP-1) will be measured in plasma isolated from blood samples obtained before and up to 3 hours after the consumption of each meal. The levels of triglycerides and relevant organic and fatty acids will also be determined.
Before recruitment volunteers will be screened for eligibility based on glucose levels, BMI and glycemic response to white bread. Additional measurements taken at the screening will include blood pressure values and blood lipids levels. All participants will be characterized for the activity of salivary a-amylase and copies of a-amylase gene (AMY1).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hyperglycemia, Postprandial, Healthy
Keywords
Polyphenols, Hyperglycemia, Postprandial, Starch, Alpha-amylase
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
24 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Enriched pomegranate juice
Arm Type
Experimental
Arm Description
Participants will consume 200 ml of pure pomegranate juice enriched with grape seed and apple peel extracts concomitantly with 109 g of white bread
Arm Title
Placebo beverage
Arm Type
Placebo Comparator
Arm Description
Participants will consume 200 ml of placebo drink concomitantly with 109 g of white bread
Intervention Type
Dietary Supplement
Intervention Name(s)
Enriched pomegranate juice
Intervention Description
Pure pomegranate juice enriched with grape seed and apple peel extract (200 ml) to be consumed with 109 g of bread
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo beverage
Intervention Description
Beverage containing the same type and amount of carbohydrates as pomegranate juice and similar flavor (200 ml) to be consumed with 109 g of bread
Primary Outcome Measure Information:
Title
Changes in maximal incremental plasma glucose level (iCmax) between baseline and endpoint within the intervention group vs. placebo control.
Description
The incremental glucose levels will be determined for each time point (at 15, 30, 45, 60, 90, 120, 150 and 180 min) as the change in plasma glucose levels after the consumption of enriched pomegranate juice or placebo drink concomitantly with white bread, compared to the glucose levels before the consumption of test meals (baseline value, t=0min).
Time Frame
Baseline, 15 min, 30 min, 45 min, 60 min, 90 min, 120 min, 150 min, 180 min.
Secondary Outcome Measure Information:
Title
Changes in area under the curve of incremental plasma glucose levels (iAUC) in the intervention group vs. placebo control.
Description
The glucose iAUC will be determined from all incremental plasma glucose levels at the defined time points (0, 15, 30, 45, 60, 90, 120, 150 and 180 min) after the consumption of test and control meals based on trapezoid rule.
Time Frame
Baseline, 15 min, 30 min, 45 min, 60 min, 90 min, 120 min, 150 min, 180 min.
Title
Changes in plasma insulin levels between baseline and endpoint within the intervention group vs. placebo control.
Description
Insulin levels measured at the baseline and at each time point (at 15, 30, 45, 60, 90,120, 150 and 180 min) after the consumption of test and control meals.
Time Frame
Baseline, 15 min, 30 min, 45 min, 60 min, 90 min, 120 min, 150 min, 180 min.
Title
Changes in plasma gastric inhibitory peptide (GIP) levels between baseline and endpoint within the intervention group vs. placebo control.
Description
GIP levels measured in plasma at the baseline and at each time point (at 15, 30, 45, 60, 90,120, 150 and 180 min) after the consumption of test and control meals.
Time Frame
Baseline, 15 min, 30 min, 45 min, 60 min, 90 min, 120 min, 150 min, 180 min.
Title
Changes in glucagon-like peptide-1 (GIP-1) levels between baseline and endpoint within the intervention group vs. placebo control.
Description
GLP-1 levels measured in plasma at the baseline and at each time point (at 15, 30, 45, 60, 90,120, 150 and 180 min) after the consumption of test and control meals.
Time Frame
Baseline, 15 min, 30 min, 45 min, 60 min, 90 min, 120 min, 150 min, 180 min.
Other Pre-specified Outcome Measures:
Title
Changes in organic acids profile between baseline and endpoint within the intervention group vs. placebo control.
Description
Levels of selected organic acids measured in plasma at the baseline and at each time point (at 15, 30, 45, 60, 90,120, 150 and 180 min) after the consumption of test and control meals.
Time Frame
Baseline, 15 min, 30 min, 45 min, 60 min, 90 min, 120 min, 150 min, 180 min.
Title
Changes in fatty acids profile between baseline and endpoint within the intervention group vs. placebo control.
Description
Levels of selected free-fatty acids measured in serum at the baseline and at each time point (at 15, 30, 45, 60, 90,120, 150 and 180 min) after the consumption of test and control meals.
Time Frame
Baseline, 15 min, 30 min, 45 min, 60 min, 90 min, 120 min, 150 min, 180 min.
Title
Changes in triglycerides levels between baseline and endpoint within the intervention group vs. placebo control.
Description
Levels of triglycerides measured in serum at the baseline and at each time point (at 15, 30, 45, 60, 90,120, 150 and 180 min) after the consumption of test and control meals.
Time Frame
Baseline, 15 min, 30 min, 45 min, 60 min, 90 min, 120 min, 150 min, 180 min.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Fasting glucose ≤ 5.6 mM;
Body mass index (BMI) ≤ 30;
Max glucose after the consumption of app. 109g of white bread less than about 8-9 mM (which is typical for the subjects we have measured previously);
Exclusion Criteria:
Smoking;
Participating in another trial that requires blood collection;
Diagnosed with any chronic illness (including diabetes, hypertension etc.);
On long term prescribed medication (except contraceptives);
Pregnant or lactating;
On a special diet or dietary regimen (for weight management or if regularly consuming fruit extract supplements);
Allergy to fruits vegetables or pollen.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Gary Williamson, PhD
Phone
+441133438380
Email
G.Williamson@leeds.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Aleksandra Konic Ristic, PhD
Phone
+441133432979
Email
A.KonicRistic@leeds.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gary Williamson, PhD
Organizational Affiliation
University of Leeds
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Aleksandra Konic Ristic, PhD
Organizational Affiliation
University of Leeds
Official's Role
Principal Investigator
Facility Information:
Facility Name
School of Food Science and Nutrition, University of Leeds
City
Leeds
State/Province
West Yorkshire
ZIP/Postal Code
LS2 9JT
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gary Williamson, PhD
Phone
+441133438380
Email
G.Williamson@leeds.ac.uk
First Name & Middle Initial & Last Name & Degree
Aleksandra Konic Ristic, PhD
Phone
+441133432979
Email
a.konicristic@leeds.ac.uk
First Name & Middle Initial & Last Name & Degree
Aleksandra Konic Ristic, PhD
First Name & Middle Initial & Last Name & Degree
Hilda Nyambe, PhD
First Name & Middle Initial & Last Name & Degree
Asimina Kerimi, PhD
First Name & Middle Initial & Last Name & Degree
Sarka Tumova, PhD
12. IPD Sharing Statement
Plan to Share IPD
Yes
Learn more about this trial
Effects of Enriched Fruit Juice on Blood Glucose Levels After a Meal in Healthy Subjects
We'll reach out to this number within 24 hrs